Asymmetric (ADMA) and Symmetric (SDMA) Dimethylarginines in Chronic Kidney Disease: A Clinical Approach

Asymmetric (ADMA) and Symmetric (SDMA) Dimethylarginines in Chronic Kidney Disease: A Clinical Approach

Asymmetric dimethylarginine (ADMA) and its enantiomer, Symmetric dimethylarginine (SDMA), are naturally occurring amino acids that were first isolated and characterized in human urine in 1970. ADMA is the most potent endogenous inhibitor of nitric oxide synthase (NOS), with higher levels in patients...

Full description

Bibliographic Details
Main Authors: Elena Oliva-Damaso, Nestor Oliva-Damaso, Francisco Rodriguez-Esparragon, Juan Payan, Eduardo Baamonde-Laborda, Fayna Gonzalez-Cabrera, Raquel Santana-Estupiñan, Jose Carlos Rodriguez-Perez
Format: Article
Language:English
Published: MDPI AG 2019-07-01
Series:International Journal of Molecular Sciences
Subjects:
ADMA
SDMA
methylarginines
asymmetric dimethylarginine
symmetric dimethylarginine
cardiovascular
chronic kidney disease
end-stage renal disease
uremia
Online Access:https://www.mdpi.com/1422-0067/20/15/3668

Internet

https://www.mdpi.com/1422-0067/20/15/3668

Similar Items